Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Triptorelin industry 360° synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Drug type trends
2.1.3 Application trends
2.1.4 Product form trends
2.1.5 Route of administration trends
2.1.6 Distribution channel trendss
2.1.7 Regional trends
Chapter 3 Triptorelin Industry Insights
3.1 Industry landscape, 2018-2032
3.2 Industry ecosystem analysis
3.2.1 Vendor matrix
3.2.2 Distribution channel analysis
3.3 Pricing analysis, 2018 - 2032
3.3.1 Pricing analysis, by region
3.3.2 Pricing analysis, by country
3.4 Cost structure analysis
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Rising incidence of cancer worldwide
3.5.1.2 Increasing drug related research and development activities
3.5.1.3 Growing number of women population base suffering from endometriosis
3.5.1.4 Upsurge in awareness regarding precocious puberty
3.5.2 Industry pitfalls & challenges
3.5.2.1 High costs associated with triptorelin drugs
3.5.2.2 Adverse price control policies
3.6 Growth potential analysis
3.6.1 By application
3.6.2 By drug type
3.6.3 By product form
3.6.4 By route of administration
3.6.5 By distribution channel
3.7 COVID- 19 impact analysis
3.8 Regulatory landscape
3.8.1 U.S.
3.8.2 Europe
3.8.3 Asia pacific
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape
4.1 Introduction
4.1.1 Ipsen Pharma
4.1.2 Ferring B.V.
4.1.3 Merck & Co., Inc.
4.2 Competitive dashboard, 2021
4.3 Company market share, 2021
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Triptorelin Market, By Drug Type
5.1 Key application trends
5.2 Triptorelin pamoate
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Triptorelin acetate
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Triptorelin embonate
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Triptorelin Market, By Application
6.1 Key application trends
6.2 Cancer
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.2 Prostate cancer
6.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.3 Breast cancer
6.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.4 Cervix uteri
6.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.5 Ovary cancer
6.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.6 Testis
6.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.7 Others
6.2.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Radical prostatectomy
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Central precocious puberty
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Endometriosis
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Hormone therapy
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.7 Uterine fibroids
6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.8 Others
6.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Triptorelin Market, By Product Form
7.1 Key product form trends
7.2 Lyophilized powder
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Pre-filled syringes
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Vials
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Triptorelin Market, By Route of Administration
8.1 Key route of administration trends
8.2 Intradermal
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Intramuscular
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Subcutaneous
8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Triptorelin Market, By Distribution Channel
9.1 Key distribution channel trends
9.2 Hospital pharmacy
9.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.3 Retail pharmacy
9.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.4 Online pharmacy
9.5 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 10 Triptorelin Market, By Region
10.1 Key regional trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Russia
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Thailand
10.4.7 Vietnam
10.4.8 Philippines
10.4.9 CIS
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Guatemala
10.5.5 Colombia
10.5.6 Costa Rica
10.5.7 Chile
10.5.8 Peru
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 South Africa
10.6.3 UAE
10.6.4 Iraq
10.6.5 Yemen
10.6.6 Lebanon
10.6.7 Syria
Chapter 11 Company Profiles
11.1 Dr. Reddy’s Laboratories Ltd
11.2 Varian Pharmed
11.3 Ferring Pharmaceuticals Pvt Ltd
11.4 Debiopharm Group
11.5 Ipsen Pharma
11.6 BACHEM
11.7 Merck KGaA
11.8 LGM Pharma
11.9 Taj Pharmaceuticals
11.10 Azurity Pharmaceuticals, Inc.
11.11 Anhui Anke Bioengineering (Group) Co., Ltd.
11.12 Verity Pharmaceuticals
11.13 Biozenta Lifescience Pvt. Ltd
